• admin@ataxiatelangiectasia.es
Ataxia-telangiectasia
  • Início
  • O que é A-T?
  • Notícias
  • Ataxia-telangiectasia: A new remitting form with a peculiar transcriptome signature
  • ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
  • Development of global rating instruments for pediatric patients with ataxia telangiectasia.
  • Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
  • In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia.
  • Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: results of a phase 2 trial.
  • Mild Neurological Phenotype Associated with Hypomorphic Variants in the Ataxia-Telangiectasia Mutated Gene

Language

  Português Brasileiro (pt-BR)
  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

Ataxia-telangiectasia
  • Início
  • O que é A-T?
  • Notícias
  • admin@ataxiatelangiectasia.es